Locally advanced stage cervical cancer diagnosed during pregnancy is a clinical challenge and requires skill in balancing maternal management, fetal care, and oncological treatment. Cisplatin has been routinely used as a first line agent for neoadjuvant chemotherapy in this situation, even though it has also recently been associated with fetal hearing loss. We report a case of stage IB3 cervical cancer diagnosed at 17 gestational weeks successfully treated with neoadjuvant chemotherapy using carboplatin and paclitaxel during pregnancy. Carboplatin is a valid alternative to cisplatin for advanced stage cervical carcinoma in a pregnant patient, in particular in view of the neonatal complications (primarily ototoxicity) that are associated with in utero cisplatin exposure.
Get full access to this article
View all access options for this article.
References
1.
AmantF, HalaskaMJ, FumagalliM, et al.Gynecologic Cancers in Pregnancy Guidelines of a Second International Consensus Meeting. Int J Gynecol Cancer. 2014; 24(3):394–403.
2.
KumarL, HarishP, MalikPS, KhuranaS. Chemotherapy and targeted therapy in the management of cervical cancer. Curr Probl Cancer. 2018; 42(2):120–8.
3.
KimHS, SardiJE, KatsumataN, et al.Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis. Euro J Surg Oncol. 2013; 39(2):115–24.
4.
RydzewskaL, TierneyJ, ValeCL, SymondsPR. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer (Review). Cochrane Database Syst Rev. 2012; 12:CD007406.
5.
KorenG, CareyN, GagnonR, et al.Cancer Chemotherapy and Pregnancy. J Obstet Gynaecol Can. 2013; 35(3);263–78.
6.
AmantF. Vandenbroucke T, Verheecke M. Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med. 2016; 374(7):693.
7.
KitagawaR, KatsumataN, ShibataT, et al.Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505. J Clin Oncol. 2015; 33(19):2129–35.
8.
SongY, LiuY, LinM, et al.Efficacy of neoadjuvant platinum-based chemotherapy during the second and third trimester of pregnancy in women with cervical cancer: an updated systematic review and meta-analysis. Drug Des Dev Ther. 2019; 79–102.
9.
GeijtemanEC, WensveenCW, DuvekotJJ, van ZuylenL. A Child with severe hearing loss associated with maternal cisplatin treatment during pregnancy. Obstet Gynecol. 2014;124(2 Pt 2 Suppl 1)454–6.
10.
HalaskaMJ, UzanC, HanSN, et al.Characteristics of patients with cervical cancer during pregnancy: a mullticenter matched cohort study. An initiative from the International Netwrok on Cancer, Infertility and Pregnancy. Int J Gynaecol Cancer. 2019 [Epub ahead of print]; DOI: 10.1136/ijgc-2018-000103.
11.
ChunKC, KimDY, KimJH, et al.Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports. Jpn J Clin Oncol. 2010; 40(7):694–8.
12.
KohlerC, OppeltP, FaveroG, et al.How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy. Am J Obstet Gynecol. 2015; 203(2):206.e1–5.
13.
BhatlaN, DennyL. FIGO CANCER REPORT 2018 Cancer of the cervix uteri. Int J Gynecol Obstet. 2018; 143 (Suppl. 2):22–36.
CalsterenKV, VerbesseltR, DevliegerR, et al.Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer. 2010; 20(9):1456–64.
16.
CibulaD, PötterR, PlanchampF, et al.The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Radiother Oncol. 2018; 127(3):404–16.
17.
de HaanJ, VerheeckeM, Van CalsterenK, et al.Oncological management and pregnancy outcomes in women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol, 2018; 19(3):337–46.
18.
AmantF, von MinckwitzG, HanSN, et al.Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol. 2013; 31(20):2532–40.
19.
ZagouriF, SergentanisTN, ChrysikosD, BartschR. Platinum derivatives during pregnancy in cervical cancer. Obstet Gynecol. 2013; 121(2 Pt 1):337–43.
20.
FruscioR, de HaanJ, Van CalsterenK, et al.Ovarian cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2017; 41:108–17.
21.
HanSN, KesicVI, Van CalsterenK, et al.Cancer in pregnancy: a survey of current clinical practice. Eur J Obstet Gynecol Reprod Biol. 2012; 167(1):18–23.
22.
Van CalsterenK, HeynsL, De SmetF. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010; 28(4);683–9.
23.
AmantF, Van CalsterenK, HalaskaMJ, et al.Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012; 13(3):256–64.
24.
AvilésA, NeriN. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma. 2001; 2(3):173–7.
25.
MarthC, LandoniF, MahnerS, et al.Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; 29(Suppl 4):iv262.
26.
PerroneAM, BovicelliA, D'AndrilliG, et al.Cervical cancer in pregnancy: analysis of the literature and innovative approaches. J Cell Physiol. 2019; 234(9):14975–90.
